Topic
Kickbacks
273 published works
Commercial Litigation Update
Four Years After Enactment – Clinical Laboratories Should Not Forget About EKRA
By Melissa L. Jampol, Zachary S. Taylor
It has been four years since Congress enacted the Eliminating Kickbacks in Recovery Act (“EKRA”), codified at 18 U.S.C. § 220. EKRA initially targeted patient brokering and kickback schemes within…
Health Care and Life Sciences
Biogen Settlement Summary
By Eve Costopoulos, Dominick DiSabatino
On Monday September 26, the Department of Justice announced a settlement resolving a lawsuit filed by former employee Michael Bawduniak (the “Plaintiff”) against Biogen Inc. (the “Company”) under the qui…
Health Law Diagnosis
The DOJ Continues to Prosecute Providers for Fraudulent Telemarketing and Telehealth
By Robinson+Cole's Health Law Group
A physician in Washington state pled guilty on September 28, 2022, to a criminal charge of conspiring to accept kickbacks related to fraudulent genetic testing. According to the Department of…
Rivkin Rounds
Pharmacy Owners Charged for Fraud and Kickbacks to a Marketing Company
The U.S. Department of Justice recently announced that a federal grand jury has charged two pharmacy owners, a mother-daughter duo from South Florida, with healthcare fraud, wire fraud, and payment…
Health Care Law Matters
US Department of Health and Human Services Office of Inspector General Warns Providers of Suspect Telemedicine Arrangements through Special Fraud Alert
While the rise of telehealth has brought us a plethora of advantages in the past two years, the concern of heightened fraud and abuse risks must not be overlooked. On…
Rivkin Rounds
Fraud Week: Unlucky Pharmacist
By Eric Fader
Rivkin Rounds' first Fraud Week kicks off with kickbacks. The U.S. Department of Justice (DOJ) recently announced that the owner of Boerne Drug in Boerne, Texas was indicted on conspiracy…
The FCA Insider
Pharmaceutical Manufacturer Agrees to $900M False Claims Act Settlement to Resolve Kickback Claims
By Michael J. Podberesky, Kate Hardey, James E. Lego, Samuel C. Bernstein
On July 20, Biogen Inc. agreed to pay $900 million to settle claims the company violated the False Claims Act by allegedly paying improper consulting and speaker fees and providing…
Subject to Inquiry
Pharmaceutical Manufacturer Agrees to $900 Million Dollar False Claims Act Settlement to Resolve Kickback Claims
By Michael J. Podberesky, Samuel C. Bernstein
On July 20th, on the eve of trial, Biogen Inc. agreed to pay $900 million dollars to settle claims that the company violated the False Claims Act (FCA) by allegedly…
Healthcare Law Blog
Eighth Circuit: In False Claims Act Cases Based On Kickback Violations, the Kickback Violation Must Be the “But For” Cause of the Items and Services Subject to the Claim
The Eighth Circuit Court of Appeals recently tossed a $5.5 million jury verdict finding that a physician violated the False Claims Act (“FCA”) by submitting claims for items and services…
Rivkin Rounds
Spinal Device Distributor, Owners and PODs Settle Kickback Claims for $1 Million
By Eric Fader
The U.S. Department of Justice (DOJ) recently announced that Reliance Medical Systems LLC, a Utah-based distributor of spinal implant devices, two of its individual owners, and two of its physician-owned…